Nexien BioPharma (NXEN) Stock Chart & Stock Price History → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free NXEN Stock Alerts $0.03 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Nexien BioPharma Stock Price Performance5 Day Performance0.00%1 Month Performance+37.81%3 Month Performance+14.87%6 Month Performance-5.86%Year-To-Date Performance+7.14%1 Year Performance-30.75% Receive NXEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexien BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. NXEN Stock Chart for Sunday, June, 9, 2024 NXEN Chart by TradingView Nexien BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$0.03$0.03$0.03$0.031,017 shs$1.95 million06/06/2024$0.03$0.03$0.03$0.031,017 shs$1.95 million06/05/2024$0.03$0.03$0.03$0.0321,009 shs$1.95 million06/04/2024$0.02$0.03+16.39%$0.03$0.0210,008 shs$1.87 million06/03/2024$0.02$0.02+16.39%$0.02$0.0218,128 shs$1.61 million05/31/2024$0.02$0.02+0.24%$0.02$0.0225,124 shs$1.38 million Get the Latest News and Ratings for NXEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nexien BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$0.02$0.02-2.86%$0.02$0.0225,124 shs$1.38 million05/29/2024$0.02$0.02+28.05%$0.02$0.028,000 shs$1.42 million05/28/2024$0.02$0.02$0.02$0.029,000 shs$1.11 million05/24/2024$0.02$0.02$0.02$0.029,000 shs$1.11 million05/23/2024$0.02$0.02-21.90%$0.02$0.029,000 shs$1.11 million05/22/2024$0.02$0.02$0.02$0.024 shs$1.42 million05/21/2024$0.02$0.02+28.83%$0.02$0.0254,000 shs$1.42 million05/20/2024$0.02$0.02-8.94%$0.02$0.029,000 shs$1.10 million05/17/2024$0.02$0.02+1.13%$0.02$0.029,000 shs$1.21 million05/16/2024$0.02$0.02-15.71%$0.02$0.025,942 shs$1.19 million05/15/2024$0.02$0.02+28.83%$0.02$0.0230,273 shs$1.42 million05/14/2024$0.02$0.02$0.02$0.021,727 shs$1.10 million05/13/2024$0.02$0.02-28.19%$0.02$0.021,839 shs$1.10 million05/10/2024$0.02$0.02+12.94%$0.02$0.027,154 shs$1.53 million05/09/2024$0.02$0.02+23.31%$0.02$0.024,167 shs$1.36 million05/08/2024$0.02$0.02$0.02$0.025,913 shs$1.10 million05/07/2024$0.02$0.02$0.02$0.0220,004 shs$1.10 million05/06/2024$0.02$0.02-2.40%$0.02$0.0220,004 shs$1.10 million05/03/2024$0.02$0.02+2.45%$0.03$0.028,862 shs$1.13 million05/02/2024$0.03$0.02-41.37%$0.02$0.0250,276 shs$1.10 million05/01/2024$0.02$0.03+68.48%$0.03$0.022,517 shs$1.88 million04/30/2024$0.02$0.02-3.51%$0.02$0.0213,332 shs$1.11 million04/29/2024$0.02$0.02+1.79%$0.02$0.022,794 shs$1.15 million04/26/2024$0.02$0.02-17.04%$0.02$0.024,032 shs$1.13 million04/25/2024$0.02$0.02-3.11%$0.02$0.021,221 shs$1.37 million04/24/2024$0.03$0.02-27.93%$0.02$0.025,914 shs$1.41 million04/23/2024$0.02$0.03+77.91%$0.03$0.029,459 shs$1.96 million04/22/2024$0.03$0.02-43.79%$0.02$0.026,001 shs$1.10 million04/19/2024$0.02$0.03+44.28%$0.03$0.025,792 shs$1.96 million04/18/2024$0.02$0.02+23.31%$0.02$0.0211,000 shs$1.36 million04/17/2024$0.03$0.02-43.79%$0.02$0.0210,394 shs$1.10 million04/16/2024$0.03$0.03$0.03$0.031,622 shs$1.96 million04/15/2024$0.02$0.03+40.10%$0.03$0.02720 shs$1.96 million04/12/2024$0.02$0.02+26.99%$0.03$0.02900 shs$1.40 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/11/2024$0.02$0.02$0.02$0.0210,378 shs$1.10 million04/10/2024$0.02$0.02$0.02$0.0225,578 shs$1.10 million04/09/2024$0.02$0.02-19.70%$0.02$0.024,226 shs$1.10 million04/08/2024$0.03$0.02-31.19%$0.02$0.021,820 shs$1.37 million04/05/2024$0.03$0.03-0.34%$0.03$0.0347,143 shs$1.98 million04/04/2024$0.03$0.03+0.34%$0.03$0.0315,337 shs$1.99 million04/03/2024$0.02$0.03+28.38%$0.03$0.0347,143 shs$1.98 million04/02/2024$0.02$0.02+40.49%$0.02$0.025,500 shs$1.55 million04/01/2024$0.02$0.02$0.02$0.029,900 shs$1.10 million03/29/2024$0.02$0.02$0.02$0.026,032 shs$1.10 million03/28/2024$0.02$0.02-20.10%$0.02$0.026,032 shs$1.10 million03/27/2024$0.02$0.02+0.25%$0.02$0.024,966 shs$1.38 million03/26/2024$0.02$0.02-0.25%$0.02$0.024,145 shs$1.37 million03/25/2024$0.02$0.02+25.15%$0.02$0.024,145 shs$1.38 million03/22/2024$0.02$0.02-22.47%$0.02$0.02181 shs$1.10 million03/21/2024$0.02$0.02+0.12%$0.02$0.028,569 shs$1.42 million03/20/2024$0.02$0.02+28.83%$0.02$0.028,569 shs$1.42 million03/19/2024$0.02$0.02-20.10%$0.02$0.0226,804 shs$1.10 million03/18/2024$0.02$0.02+25.15%$0.03$0.024,191 shs$1.38 million03/15/2024$0.03$0.02-45.30%$0.02$0.021,704 shs$1.10 million03/14/2024$0.02$0.03+76.33%$0.03$0.03193 shs$2.01 million03/13/2024$0.02$0.02+3.68%$0.02$0.0221,338 shs$1.14 million03/12/2024$0.02$0.02-22.38%$0.03$0.022,689 shs$1.10 million03/11/2024$0.02$0.02-12.92%$0.02$0.028,062 shs$1.42 million03/08/2024$0.03$0.02-19.67%$0.03$0.02873 shs$1.63 million Related Companies: ASLAN Pharmaceuticals Stock Price Chart Cadrenal Therapeutics Stock Price Chart Integrated BioPharma Stock Price Chart Cyclerion Therapeutics Stock Price Chart Trevena Stock Price Chart Universe Pharmaceuticals Stock Price Chart TransCode Therapeutics Stock Price Chart First Wave BioPharma Stock Price Chart Pulmatrix Stock Price Chart Tenax Therapeutics Stock Price Chart Receive NXEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nexien BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NXEN) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexien BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexien BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.